BOSTON SCIENTIFIC CORP 4

SVP Emily Woodworth indirectly acquired 2,930 shares of Boston Scientific common stock via a 401(k) plan rebalancing transaction.

On August 11, 2026, Emily Woodworth, SVP, Global Controller and CAO of Boston Scientific Corp, acquired 2,930 shares of the company’s common stock within her 401(k) plan pursuant to an election to rebalance her retirement holdings, a discretionary but routine plan-related transaction. The shares were acquired at an indicated price of approximately $51.19 per share, implying an aggregate transaction value of about $150,000, and are held indirectly through the company’s 401(k) Retirement Savings Plan. Following this transaction, she beneficially owns 3,123 shares of Boston Scientific common stock (including shares under the Employee Stock Purchase Plan), which are worth roughly $160,000 based on the recent trading price. The filing characterizes the move as a rebalancing election rather than an open‑market trade, suggesting it is primarily administrative portfolio management within a retirement plan rather than a directional bet on the stock.

Filing Facts

CIK

885725

Ticker

BSX

Form

4

Source Type

sec

Accession

0001225208-26-007084

Alert Tier

6